HomeNDC LookupRxCUI directory › RxCUI 1797929

Budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray — RxCUI 1797929

RxNorm drug concept · Semantic clinical drug
RxCUI 1797929 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 8 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1797929
Official nameBudesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbudesonide 32 MCG/ACTUAT Metered Dose Nasal Spray
FDA products mapped6
Package NDCs mapped8
Reported Medicaid activity (SDUD)20,113 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Budesonide Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You might notice some improvement on the very first day, but don't give up if you don't feel a big difference right away. The full benefit from this spray usually builds up over ab...
  • How long does it take for budesonide nasal spray to actually work?
  • Children 6 and older can use budesonide nasal spray, but an adult should supervise use for kids ages 6 to under 12. The spray should not be used in children under 6. One thing to k...
  • Can my child use this spray, and is it safe for long-term use in kids?
📖 Read our full Budesonide Nasal Spray guide →

🕸️ Concept Web — How Budesonide 0.032 MG/ACTUAT Metered Dose Nasal Sp... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray RxCUI 1797929

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Budesonide 19831
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Rhinocort 196488
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Budesonide Metered Dose Nasal Spray 1797928
    • Budesonide Inhalant Product 1156070
    • Budesonide Nasal Product 1156071
    • Budesonide Metered Dose Nasal Spray [Rhinocort] 1797930
    • Rhinocort Inhalant Product 1183592
    • Rhinocort Nasal Product 1183593
    • Metered Dose Nasal Spray 1797831
    • Inhalant Product 1151123
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Budesonide 0.032 MG/ACTUAT 315498
    • Budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray [Rhinocort] 1797931
    • Budesonide 0.032 MG/ACTUAT [Rhinocort] 566387

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Budesonide 0.032 MG/ACTUAT SCDC · 315498
  • Budesonide Metered Dose Nasal Spray SCDF · 1797928
  • Budesonide Inhalant Product SCDG · 1156070
  • Budesonide Nasal Product SCDG · 1156071

Brand-Name Concepts

  • Budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray [Rhinocort] SBD · 1797931
  • Budesonide 0.032 MG/ACTUAT [Rhinocort] SBDC · 566387
  • Budesonide Metered Dose Nasal Spray [Rhinocort] SBDF · 1797930
  • Rhinocort Inhalant Product SBDG · 1183592
  • Rhinocort Nasal Product SBDG · 1183593
  • Rhinocort BN · 196488

📦 FDA Products & Package NDCs

6 products · 8 package NDCs
8 package NDCs map to RxCUI 1797929 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-0048-01 1 BOTTLE, SPRAY in 1 BOTTLE, SPRAY (0363-0048-01) / 120 SPR... Budesonide Walgreens 2025-07-01
00536-1112-48 1 BOTTLE, SPRAY in 1 CARTON (0536-1112-48) / 120 SPRAY, MET... Budesonide Rugby Laboratories 2016-07-27
00536-1456-84 1 BOTTLE, SPRAY in 1 CARTON (0536-1456-84) / 120 SPRAY, MET... Budesonide Rugby Laboratories 2025-12-01
49035-0703-01 1 BOTTLE, SPRAY in 1 BOTTLE, SPRAY (49035-703-01) / 120 SPR... Budesonide EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) 2025-07-01
60505-6129-02 1 BOTTLE, SPRAY in 1 BOTTLE, SPRAY (60505-6129-2) / 120 SPR... Budesonide Apotex Corp. 2016-04-19
60505-6129-06 2 BOTTLE, SPRAY in 1 CARTON (60505-6129-6) / 120 SPRAY, MET... Budesonide Apotex Corp. 2016-04-19
60505-6129-07 3 BOTTLE, SPRAY in 1 CARTON (60505-6129-7) / 120 SPRAY, MET... Budesonide Apotex Corp. 2016-04-19
69842-0001-01 1 BOTTLE, SPRAY in 1 BOTTLE, SPRAY (69842-001-01) / 120 SPR... Budesonide CVS Pharmacy 2025-07-01
Observed labelers: Apotex Corp. (3) · Rugby Laboratories (2) · CVS Pharmacy (1) · EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) (1) · Walgreens (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.3880
Range $1.3880–$1.3880 · middle 50% $1.3880–$1.3880 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.